Seasonal rhinitis and azelastine: Long- or short-term treatment?

Journal of Allergy and Clinical Immunology

Volumn 99, Issue 3, 1997, Pages 301-307

  Ciprandi, Giorgio ^a   Ricca, Vittorio ^a   Passalacqua, Giovanni ^a   Truffelli, Tiziana ^a   Bertolini, Claudia ^a   Fiorino, Nicola ^a   Riccio, Anna Maria ^a   Bagnasco, Marcello ^a   Canonica, Giorgio Walter ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

allergic inflammation; Azelastine; seasonal rhinitis

Indexed keywords

ALKALINE PHOSPHATASE; ALLERGEN; ANTIHISTAMINIC AGENT; AZELASTINE; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY;

ADULT; ALLERGY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EOSINOPHIL; EPITHELIUM CELL; FEMALE; GRASS POLLEN; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MALE; NEUTROPHIL; NOSE MUCOSA; NOSE SMEAR; PRICK TEST; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SYMPTOM; TOPICAL DRUG ADMINISTRATION;

EID: 0030961990     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70046-0     Document Type: Article

References (22)

1. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1993;94:427-38.
2. Ciprandi G, Pronzato C, Ricca V, Bagnasco M, Canonica GW. Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure. J Allergy Clin Immunol 1994;94:738-46.
3. Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Bagnasco M, Canonica GW. Allergen-specific challenge induces intracellular adhesion molecule-1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Am J Respir Crit Care Med 1994;150:1653-9.
4. Canonica GW, Pronzato C, Fiorino N, Ciprandi G, Bagnasco M. Adhesion molecules: A review of their clinical roles in allergic inflammation. Allergy Clin Immun News 1993;5:80-4.
5. Canonica GW, Ciprandi G, Buscaglia S, Pesce GP, Bagnasco M. The adhesion molecules of allergic inflammation: Recent insights into their functional roles. Allergy 1994;49:135-41.
6. Ciprandi G, Buscaglia S, Pesce GP, Bagnasco M, Canonica GW. ICAM-1/CD54 expression on conjunctival epithelium during pollen season. Allergy 1995;50:184-7.
7. Ciprandi G, Buscaglia S, Pesce GP, Villaggio B, Bagnasco M, Canonica GW. Allergic subjects express intercellular adhesion molecules-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge. J Allergy Clin Immunol 1993;91:783-92.
8. Ciprandi G, Buscaglia S, Pesce GP, Pronzato C, Ricca V, Parmiani S, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995;96:971-9.
9. Ciprandi G, Buscaglia S, Pesce GP, Bagnasco M, Canonica GW. Ocular challenge and hyperresponsiveness to histamine in patients with allergic conjunctivitis. J Allergy Clin Immunol 1993; 91:1227-30.
10. Ciprandi G, Buscaglia S, Pesce GP, Lotti R, Rolando M, Bagnasco M, Canonica GW. Effects of conjunctival hyperosmolar challenge in allergic subjects and normal controls. Int Arch Allergy Appl Immunol 1994;104:92-6.
11. Scordamaglia A, Paolieri F, Battifora M, Milanese M, Riccio AM, Bagnasco M, et al. Budesonide in vitro activity on a human continuous bronchial cell line: Expression of ICAM-1. Allergy, Suppl. 1995;26,50:266.
12. Ciprandi G, Pronzato C, Ricca V, Varese P, Del Giacco GS, Canonica GW. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy. Clin Exp Allergy 1995;25:871-8.
13. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, McDonald S, et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAAP complexes). J Histochem Cytochem 1984;32:219-45.
14. McTavish D and Sorkin EM. Azelastine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1984;38:778-800.
15. Chand N, Pillar J, Diamantis W, Sofia RD. Inhibition of IgE mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic durgs. Agents Actions 1985;16: 318-22.
16. Fields DAS, Pillar J, Diamantis W, Perhach JL Jr, Sofia RD, Johnstone AJ, et al. Inhibition by azelastine of non allergic histamine release from rat peritoneal mast cells. J Allergy Clin Immunol 1984;73:400-3.
17. Fisher B, Schmutzier W. Inhibition by azelastine of immunologically induced histamine release from isolated guinea pig mast cells. Arzneimittelforschung 1981;31:1193-5.
18. Katayama S, Tsunoda H, Sakuma Y, Kai H, Tanaka I, Fakura O, et al. Effect of azelastine on the release and action of leukotriene C4 and D4. Int Arch Allergy Immunol 1987;83:284-9.
19. Shin MH, Baroody F, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. The effect of azelastine on the early allergic response. Clin Exp Allergy 1992;22:289-95.
20. Busse WW, Middleton E, Storms W. Dockhorn J, Chu TJ, Grossman J, et al. Corticosteroid-sparing effect of Azelastine in the management of bronchial asthma. Am J Resp Crit Care Med 1996;153:122-7.
21. Pelucchi A, Chiapparino A, Mastopasqua B, Marazzini L, Hernandez A, Foresi A. Effects of inranasalazelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology and bronchial responsiveness to metacholine in allergic rhinitis in response to grass pollens. J Allergy Clin Immunol 1995;95:515-23.
22. Taborda Barata L, Jacobson M, Walker S, Njuki F, Ying S, Randev P, et al. Effect of cetirizine and prendnisolene on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses. Clin Exp Allergy 1996;26:68-78.